Literature DB >> 2957062

An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family.

P Delli Bovi, A M Curatola, F G Kern, A Greco, M Ittmann, C Basilico.   

Abstract

We recently reported the cloning of a rearranged human oncogene following transfection of DNA from Kaposi's sarcoma into NIH 3T3 cells. To identify the protein(s) encoded in two novel mRNAs of 3.5 and 1.2 kb expressed in NIH 3T3 transformants, we constructed a cDNA library. One of the cDNA clones isolated (KS3) corresponded to the 1.2 kb mRNA and transformed NIH 3T3 cell when inserted into a mammalian expression vector. The 1152 nucleotide KS3 cDNA encodes a protein of 206 amino acids with significant homology to the growth factors basic FGF and acidic FGF. Expression of the KS3 product as a bacterial fusion protein or in COS cells allowed us to determine that both proteins had significant growth-promoting activity and that the COS cell protein was glycosylated. Thus one of the mRNAs transcribed from the KS oncogene encodes a growth factor that could transform cells by an autocrine mechanism and appears to represent a new member of the FGF family.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957062     DOI: 10.1016/0092-8674(87)90331-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  114 in total

1.  Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG).

Authors:  M Ruta; W Burgess; D Givol; J Epstein; N Neiger; J Kaplow; G Crumley; C Dionne; M Jaye; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

3.  Heparin-binding growth factors and their receptors.

Authors:  B B Olwin
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

4.  Putative tyrosine kinases expressed in K-562 human leukemia cells.

Authors:  J Partanen; T P Mäkelä; R Alitalo; H Lehväslaiho; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

7.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.

Authors:  D C Ambrosetti; C Basilico; L Dailey
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Assignment by in situ hybridization of a fibroblast growth factor receptor gene to human chromosome band 10q26.

Authors:  M G Mattei; A Moreau; M C Gesnel; E Houssaint; R Breathnach
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

9.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

Authors:  L Dailey; H Yuan; C Basilico
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 10.  Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.

Authors:  R S Morrison; F Yamaguchi; H Saya; J M Bruner; A M Yahanda; L A Donehower; M Berger
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.